Century Therapeutics, Inc. (IPSC)
2.025
-0.20
(-9.19%)
USD |
NASDAQ |
Aug 28, 16:00
2.025
0.00 (0.00%)
After-Hours: 20:00
Century Therapeutics Cash from Investing (Quarterly) : 17.77M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 17.77M |
| March 31, 2026 | -112.62M |
| December 31, 2025 | 22.36M |
| September 30, 2025 | 24.67M |
| June 30, 2025 | 32.54M |
| March 31, 2025 | 27.93M |
| December 31, 2024 | 30.61M |
| September 30, 2024 | 39.20M |
| June 30, 2024 | -33.86M |
| March 31, 2024 | 11.54M |
| December 31, 2023 | 18.60M |
| September 30, 2023 | 4.217M |
| June 30, 2023 | 6.974M |
| Date | Value |
|---|---|
| March 31, 2023 | 31.34M |
| December 31, 2022 | -4.273M |
| September 30, 2022 | 22.66M |
| June 30, 2022 | 12.52M |
| March 31, 2022 | -44.04M |
| December 31, 2021 | -20.60M |
| September 30, 2021 | -147.05M |
| June 30, 2021 | -11.65M |
| March 31, 2021 | -119.03M |
| December 31, 2020 | -20.78M |
| September 30, 2020 | 0.476M |
| June 30, 2020 | 1.726M |
| March 31, 2020 | -4.178M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | 0.00 |
| Manhattan Scientifics, Inc. | -- |
| Exicure, Inc. | 0.00 |
| Absci Corp. | 24.07M |
| Celularity, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -19.83M |
| Cash from Financing (Quarterly) | 0.311M |
| Free Cash Flow | -88.07M |
| Free Cash Flow Per Share (Quarterly) | -0.0998 |
| Free Cash Flow to Equity (Quarterly) | -11.17M |
| Free Cash Flow to Firm (Quarterly) | -20.53M |
| Free Cash Flow Yield | -30.35% |